Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus ‐related hepatocellular carcinoma after surgical resection: A multicenter study

ConclusionsNucleotide analog treatment, but not NsA treatment, significantly reduced the risk of HCC recurrence in patients with HBV-related HCC and improved overall survival after curative hepatic resection.

Source: Cancer Medicine - October 13, 2021 Category: Cancer & Oncology Authors: Weili Qi, Junyi Shen, Junlong Dai, Youwei Wu, Yu Zhang, Shusheng Leng, Fengwei Gao, Shun Ran, Wei Peng, Xiaoyun Zhang, Tianfu Wen, Chuan Li Tags: RESEARCH ARTICLE Source Type: research